HomeBusinessHealthcare Industry Stock NewsPfizer (PFE) CFO On Post-Covid Success With Seagen (SGEN) Acquisition

Pfizer (PFE) CFO On Post-Covid Success With Seagen (SGEN) Acquisition

This week, Pfizer (PFE) announced that it would pursue one of the two weight loss pill candidates in its pipeline. This news caused the PFE stock price to fall. Pfizer (PFE) CFO Dave Denton weighs in on the market for diabetes and obesity as it could be worth more than $100B. Pfizer (PFE) is to acquire Seagen (SGEN) for a total enterprise value of approximately $43B. This will enhance Pfizer’s position as a leading company in oncology.

Market On Close

27 Jun 2023

SHARE

ON AIR
5:00 pm
Trading 360
replay
12:00 am
Fast Market
REPLAY
education
1:00 am
Your First Trade
REPLAY
1:30 am
Next Gen Investing
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Trading 360
REPLAY
4:00 am
Fast Market
REPLAY
5:00 am
Next Gen Investing
REPLAY
education
6:00 am
Your First Trade
REPLAY
6:30 am
Trading 360
REPLAY
7:30 am
Fast Market
REPLAY
8:30 am
Next Gen Investing
REPLAY
9:30 am
Market Overtime
REPLAY
10:00 am
Trading 360
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
education
1:00 pm
Your First Trade
REPLAY
1:30 pm
Trading 360
REPLAY
2:30 pm
Fast Market
REPLAY
3:30 pm
Next Gen Investing
REPLAY
4:30 pm
Market Overtime
REPLAY
ON AIR
5:00 pm
Trading 360
REPLAY
6:00 pm
Fast Market
REPLAY
7:00 pm
Next Gen Investing
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Trading 360
REPLAY
9:30 pm
Fast Market
REPLAY
10:30 pm
Next Gen Investing
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Get the Market Minute

Daily insights for every investor

coming soon

We are now

coming soon

We are now